Literature DB >> 10225273

Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.

N Fischer1, B Kopper, N Graf, J R Schlehofer, F A Grässer, N Mueller-Lantzsch.   

Abstract

The Epstein-Barr virus (EBV) is the causative agent of infectious mononucleosis and is implicated in the development of several human malignancies. Latent membrane protein 1 (LMP1), an EBV protein with known oncogenic properties, may be important in the pathogenesis of EBV-associated tumors, particularly nasopharyngeal carcinoma (NPC) and Hodgkin's disease (HD). Several reports suggested that sequence variations in the LMP1 gene may define a more aggressive, geographically restricted EBV-genotype. Most mutations in the LMP1 gene described are located within the C-terminus of the protein. However, the effect of these mutations on the biological function of the protein remains widely unknown. Therefore, this study aimed in investigating whether mutations detected in LMP1 genes isolated from different EBV-positive carriers have an effect on the biological function of the protein. For this purpose the LMP1 genes were amplified by nested PCR from DNA out of bone marrow and peripheral blood lymphocytes and sequenced. Three functional assays were performed in order to evaluate the biological activity of the different isolates: activation of the transcription factors NF-kappaB and AP-1 as well as the anchorage independent growth of LMP1 transfected ratl cells in soft agar. The results suggested that whereas differences in the activation of NF-kappaB through the various LMP1 isolates correlated tightly with their different expression levels, the outgrowth of transfected cells in soft agar did not and the transcription factor NF-kappaB therefore appeared not to be the major effector for the transformation of the rodent cell line ratl by LMP1. The various LMP1-isolates also differed in their capacity in activating the transcription factor AP-1. We found no correlation between the transforming ability of the LMPI isolates and activation of AP-1 suggesting that other so far uncharacterized domains also influence the transforming ability of the protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225273     DOI: 10.1016/s0168-1702(98)00147-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.

Authors:  Jyotsna Pandya; Dennis M Walling
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Oncogenic activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is down-regulated by lytic LMP-1.

Authors:  Jyotsna Pandya; Dennis M Walling
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.

Authors:  M Higuchi; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

Authors:  C A Fielding; K Sandvej; A Mehl; P Brennan; M Jones; M Rowe
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.

Authors:  Kai Yu Jen; Masaya Higuchi; Jun Cheng; Jiang Li; Lan Yan Wu; Ying Fang Li; Han Liang Lin; Zhilong Chen; Vladimir Gurtsevitch; Masahiro Fujii; Takashi Saku
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

Review 7.  New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma.

Authors:  Kathy H Y Shair; Akhil Reddy; Vaughn S Cooper
Journal:  Cancers (Basel)       Date:  2018-03-21       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.